Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


FDA Approves Ravicti for Urea Cycle Disorders
Conditions inhibit ammonia removal from the body
This article is older than one year and is no longer available.

Copyright © 2013 HealthDay. All rights reserved.

August 5, 2015

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

Robotic Sx Feasible for Inferior Vena Cava Thrombectomy

U.S. Health Spending Projected to Rise 5.8 Percent By 2024

Revised Staging System Prognostic for Multiple Myeloma

Novel Pharmacological Activity for R-Ketorolac in Ovarian Cancer

Tyrosine Kinase Inhibitors Seem Safe in CML With CKD

AMA Wants Doctor Input on EHRs, Meaningful Use